Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Menopause and hormone replacement therapy

S R Johnson1

  • 1Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, USA.

The Medical Clinics of North America
|April 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deformation and Collectivity in Doubly Magic ^{208}Pb.

Physical review letters·2025
Same author

Gamma Decay of the ^{154}Sm Isovector Giant Dipole Resonance: Smekal-Raman Scattering as a Novel Probe of Nuclear Ground-State Deformation.

Physical review letters·2025
Same author

Pulmonary Lymphangioleiomyomatosis originates in the pleural mesothelial cell population.

Medical hypotheses·2020
Same author

Cancer, employment, and American Indians: A participatory action research pilot study.

Rehabilitation counseling bulletin·2019
Same author

Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Journal of scleroderma and related disorders·2018
Same author

The UK guidelines for management and surveillance of Tuberous Sclerosis Complex.

QJM : monthly journal of the Association of Physicians·2018
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Menopause is a normal life stage. Effective therapies exist for bothersome symptoms, but hormone replacement therapy (HRT) for prevention requires careful consideration pending clinical trial results.

Area of Science:

  • Reproductive Health
  • Endocrinology
  • Women's Health

Background:

  • Menopause is a natural biological transition for women.
  • Bothersome menopausal symptoms can be effectively managed with appropriate therapies.
  • The role of hormone replacement therapy (HRT) in preventing menopausal conditions is complex and under investigation.

Purpose of the Study:

  • To provide information on menopause and its management.
  • To discuss the complexities surrounding the use of HRT for prevention.
  • To highlight the importance of ongoing clinical trials in informing therapeutic recommendations.

Main Methods:

  • Review of current understanding of menopause and its symptoms.
  • Discussion of therapeutic options for menopausal symptom relief.

Related Experiment Videos

  • Examination of the status and implications of major clinical trials like the Women's Health Initiative (WHI) and Heart and Estrogen Replacement Therapy Study (HERS).

    • Main Results:

    • Effective treatments are available for bothersome menopausal symptoms.
    • The preventive use of HRT is complex and requires further investigation.
    • Large-scale randomized clinical trials are ongoing to assess HRT's impact on clinical events.

    Conclusions:

    • Clinicians should exercise caution when recommending preventive HRT.
    • Patients should be informed about the uncertainties associated with preventive HRT.
    • Recommendations for preventive HRT should await the results of major clinical trials such as WHI and HERS.